HKD 7.71
(0.13%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 151.3 Million CNY | 3.82% |
2022 | 145.72 Million CNY | -38.56% |
2021 | 237.18 Million CNY | 16.71% |
2020 | 203.22 Million CNY | 64.28% |
2019 | 123.7 Million CNY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 53.64 Million CNY | 0.0% |
2024 Q1 | 53.64 Million CNY | 104.67% |
2023 FY | 151.3 Million CNY | 3.82% |
2023 Q1 | 49.43 Million CNY | 105.53% |
2023 Q4 | 26.21 Million CNY | 0.0% |
2023 Q3 | 26.21 Million HKD | -46.98% |
2023 Q2 | 49.43 Million CNY | 0.0% |
2022 Q2 | 48.8 Million CNY | 0.0% |
2022 Q1 | 48.8 Million CNY | -30.45% |
2022 FY | 145.72 Million CNY | -38.56% |
2022 Q4 | 24.05 Million CNY | 0.0% |
2022 Q3 | 24.05 Million CNY | -50.72% |
2021 Q1 | 48.41 Million CNY | 0.0% |
2021 FY | 237.18 Million CNY | 16.71% |
2021 Q4 | 70.17 Million CNY | 0.0% |
2021 Q3 | 70.17 Million CNY | 44.95% |
2021 Q2 | 48.41 Million CNY | 0.0% |
2020 FY | 203.22 Million CNY | 64.28% |
2019 FY | 123.7 Million CNY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Life Healthcare Group Limited | 233.68 Million HKD | 35.254% |
China Biotech Services Holdings Limited | 211.98 Million HKD | 28.627% |